『Cholestatic Pruritus Associated with PBC: Understanding Unmet Patient Needs and Treatment Strategies』のカバーアート

Cholestatic Pruritus Associated with PBC: Understanding Unmet Patient Needs and Treatment Strategies

Cholestatic Pruritus Associated with PBC: Understanding Unmet Patient Needs and Treatment Strategies

著者： Annenberg Center for Health Sciences
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Pruritus occurs in up to 70% of patients with primary biliary cholangitis (PBC), can be severe, and lead to increased morbidity-including worsening fatigue and quality of sleep. Standard of care treatment has relied on a variety of medications with limited effectiveness and tolerability adding to the patient disease burden. Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team.Annenberg Center for Health Sciences 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Interprofessional Patient Case

    Interprofessional Patient Case
    2025/02/11

    Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team. They also explore safety and efficacy data from trials of emerging treatment options including ileal bile acid transporter (IBAT) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists.
    続きを読む 一部表示
    5 分
  • Investigational Therapies

    Investigational Therapies
    2025/02/11
    Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team. They also explore safety and efficacy data from trials of emerging treatment options including ileal bile acid transporter (IBAT) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists.
    続きを読む 一部表示
    5 分
  • Current Treatment Options

    Current Treatment Options
    2025/02/11

    Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team. They also explore safety and efficacy data from trials of emerging treatment options including ileal bile acid transporter (IBAT) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists.
    続きを読む 一部表示
    16 分
adbl_web_anon_alc_button_suppression_c
まだレビューはありません